Tech — Software
Health Catalyst Executive Compensation (FY25)
HCAT · South Jordan, UT · Executive and director compensation, fiscal 2022 to 2025
Data as of September 7, 2026Latest filing (8-K): July 20, 2026
330 figures on this page: 324 cited to the filing that reported them, 6 calculated from figures it prints. See the citations
Daniel Burton, Chief Executive Officer, received $3,991,159 in total compensation for fiscal 2025, and Burton's total was 27.4% lower than the $5,494,141 reported for fiscal 2024. The company reported a chief executive pay ratio of 35:1 for fiscal 2025, against median employee compensation of $113,064. The say-on-pay proposal drew 97.6% of votes cast for or against in favor at the meeting held July 16, 2026 for fiscal 2025. Companies named in the disclosed peer group include Accolade, American Well, Amplitude, Certara and Computer Programs and Systems, among others.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Daniel Burton: $5,494,141 → $3,991,159 (27.4% lower)
Say-on-pay support: 98.3% → 97.6% (0.7 points lower)
CEO pay ratio: 46:1 → 35:1 (23.9% lower)
Frequently asked questions
Answers drawn from the data on this page.
Who is Health Catalyst's chief executive and what were they paid?
Daniel Burton, Chief Executive Officer, received $3,991,159 in total compensation for fiscal 2025. Burton's total was 27.4% lower than the $5,494,141 reported for fiscal 2024.
What was Health Catalyst's say-on-pay result?
The say-on-pay proposal drew 97.6% of votes cast for or against in favor at the meeting held July 16, 2026 for fiscal 2025.
Which companies are in Health Catalyst's peer group?
Companies named in the disclosed peer group include Accolade, American Well, Amplitude, Certara and Computer Programs and Systems, among others.
What is Health Catalyst's chief executive pay ratio?
The company reported a chief executive pay ratio of 35:1 for fiscal 2025, against median employee compensation of $113,064.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Patrick Nelli Former President Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Daniel Burton Chief Executive Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Paul Horstmeier Chief Operating Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Bryan Hunt Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Kevin Freeman Chief Commercial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Daniel Orenstein General Counsel | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Bryan Hunt Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Linda Llewelyn Chief People Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Benjamin Landry General Counsel | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Daniel Orenstein General Counsel | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Jason Alger Chief Financial Officer and former Chief Accounting Officer Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Kevin Freeman Chief Commercial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Daniel Burton Chief Executive Officer | — | — | — | — | — | — | — | — not reported |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Daniel Burton Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Kevin Freeman Chief Commercial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Benjamin Landry General Counsel | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Linda Llewelyn Chief People Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Jason Alger Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Bryan Hunt Former Chief Financial Officer Departed during or after this year | ◇ | — | — | — | — | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Daniel Burton Chief Executive Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Benjamin Albert Chief Operating Officer and President | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Jason Alger Chief Financial Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Kevin Freeman Chief Commercial Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Dan LeSueur Former Chief Operating Officer Departed during or after this year | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Benjamin Landry General Counsel | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Benjamin Albert | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Benjamin Albert | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Benjamin Albert | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Benjamin Albert | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Benjamin Landry | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Benjamin Landry | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Benjamin Landry | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Dan LeSueur | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Dan LeSueur | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Dan LeSueur | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Daniel Burton | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Daniel Burton | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Daniel Burton | RSU | ◇ | — | — | — withheld | — | — | ◇ |
| Jason Alger | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Jason Alger | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Jason Alger | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Kevin Freeman | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Kevin Freeman | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Kevin Freeman | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Dan LeSueur | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Kevin Freeman | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Benjamin Albert | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Benjamin Landry | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Jason Alger | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Daniel Burton | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 9/27/28 | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
John A. Kane | ◇ | ◇ | — | — | — | — | ◇ |
Justin Spencer | ◇ | ◇ | — | — | — | — | ◇ |
Duncan Gallagher | — | ◇ | — | — | — | — | ◇ |
Julie Larson-Green | — | ◇ | — | — | — | — | ◇ |
Jill Hoggard Green | ◇ | ◇ | — | — | — | — | ◇ |
S. Dawn Smith | ◇ | ◇ | — | — | — | — | ◇ |
Anita V. Pramoda | — | ◇ | — | — | — | — | ◇ |
Steven Nelson, Mathew Arens, Daniel Burton, Matthew Kolb and Benjamin Albert served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Accolade ACCD
- American Well AMWL
- Amplitude AMPL
- Certara CERT
- Computer Programs and Systems symbol not shown
- Consensus Cloud Solutions CCSI
- Definitive Healthcare DH
- DocGo DCGO
- Domo DOMO
- Everbridge EVBG
- Grid Dynamics GDYN
- HealthStream HSTM
- Model N MODN
- National Research NRC
- Nutex Health NUTX
- OptimizeRx OPRX
- Phreesia PHR
- Sharecare SHCR
- TruBridge symbol not shown
- Upland Software UPLD
- Yext YEXT
- Zuora ZUO
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | July 16, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | July 9, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | June 13, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | June 14, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | June 14, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | June 10, 2021 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
What this page does not include
Everything above is a fact Health Catalyst disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Health Catalyst sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
330 figures on this page: 324 cited to the filing that reported them, 6 calculated from figures it prints.
324 cited to the filing
6 calculated from the filing
Documents cited
- 0001636422-26-000085
- 0001636422-26-000075CEO Pay Ratio · ELECTION OF DIRECTORS · Grants of Plan-Based Awards · Non-Employee Director Compensation · and 2 more sections
- 0001636422-25-000096Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001636422-25-0000752024 Summary Compensation Table · Director Compensation
- 0001636422-24-000097Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001636422-24-0000582023 Summary Compensation Table
- 0001636422-23-000086Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001636422-23-0000462022 Summary Compensation Table
- 0001636422-22-000027
- 0001636422-21-000052
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Health Catalyst executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/HCAT (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Health Catalyst and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Tech — Software rankings
Peers Health Catalyst discloses
The companies named in HCAT's own disclosed peer group.
Terms on this page
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}